Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-145199)

Filing Details

Accession Number:: 0001104659-16-145199
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-09-16 17:10:06
Reporting Period:: 2016-09-16

Filing Date:: 2016-09-16
Accepted Time:: 2016-09-16 17:10:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356576	Supernus Pharmaceuticals Inc	SUPN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219844	S Gregory Patrick	C/O Supernus Pharmaceuticals, Inc. 1550 East Gude Drive Rockville MD 20850	Vp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-09-16	2,000	$25.00	3,616	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Transaction made pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015, as amended May 9, 2016.